Workflow
Shenqi(600613)
icon
Search documents
神奇制药(600613) - 上海神奇制药投资管理股份有限公司关于股东股份解除质押的公告
2025-06-06 09:45
| | | 上海神奇制药投资管理股份有限公司 关于股东股份解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 上海神奇制药投资管理股份有限公司(以下简称"公司"或"本公司") 的股东贵州迈吉斯投资管理有限公司(以下简称"迈吉斯")持有公司 88,001,946 股,占公司总股本 16.48%;办理了股票质押回购交易业务,解除质 押 36,330,000 股;剩余累计质押股份 26,670,000 股,占公司总股份数 4.99%, 占其持有公司股份 30.31%。 公司控股股东贵州神奇控股(集团)有限公司(以下简称"神奇控股") 及其控股公司迈吉斯合计持有公司 178,663,566 股,占公司总股本 33.45%;累 计质押股份 87,100,000 股,占公司总股份数 16.31%,占其合计持有公司股份 48.75%。 2025 年 6 月 6 日,公司接到迈吉斯的通知,迈吉斯向国海证券股份有限公 司办理了股票质押式回购交易,解除质押 36,330,000 股。具体情况如下: 1 股东名称 ...
每周股票复盘:神奇制药(600613)2024年年度权益分派实施
Sou Hu Cai Jing· 2025-05-31 08:47
公司公告汇总 上海神奇制药投资管理股份有限公司公布了2024年年度权益分派实施公告。每股分配比例为A股每股现 金红利0.15元,B股每股现金红利0.020858美元。A股股权登记日为2025年6月4日,除权(息)日及现金 红利发放日为2025年6月5日;B股股权登记日为2025年6月9日,最后交易日为2025年6月4日,除权 (息)日为2025年6月5日,现金红利发放日为2025年6月23日。本次利润分配以方案实施前的公司总股 本534,071,628股为基数,每股派发现金红利0.15元(含税),共计派发现金红利80,110,744.20元。无限 售条件流通股的红利委托中国结算上海分公司通过其资金清算系统向股权登记日上海证券交易所收市后 登记在册并在上海证券交易所各会员办理了指定交易的股东派发。已办理指定交易的投资者可于红利发 放日在其指定的证券营业部领取现金红利,未办理指定交易的股东红利暂由中国结算上海分公司保管。 公司股东贵州神奇控股(集团)有限公司、贵州迈吉斯投资管理有限公司的现金红利由本公司直接发 放。A股自然人股东及证券投资基金的现金红利根据持股期限不同按相应税率扣缴个人所得税。B股股 东的现金红利 ...
神奇制药: 上海神奇制药投资管理股份有限公司2024年年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-05-28 10:21
Core Viewpoint - The announcement details the annual profit distribution plan of Shanghai Magic Pharmaceutical Investment Management Co., Ltd., including cash dividends for A and B shares, relevant dates, and tax implications for shareholders [1][2]. Distribution Plan - A cash dividend of 0.15 CNY per A share and 0.020858 USD per B share will be distributed, totaling 80,110,744.20 CNY based on a total share capital of 534,071,628 shares [2][5]. - The profit distribution plan was approved at the annual shareholders' meeting on May 16, 2025 [1]. Relevant Dates - For A shares: - Record date: June 4, 2025 - Ex-dividend date: June 5, 2025 - For B shares: - Record date: June 9, 2025 - Ex-dividend date: June 23, 2025 [2][3]. Dividend Distribution Method - Cash dividends for A shares will be distributed through China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders registered by the record date [2]. - B share dividends will be paid in USD, with the exchange rate set at 1:7.1916 based on the central bank's rate on May 19, 2025 [5][6]. Tax Implications - A share dividends for individual shareholders with a holding period over one year are exempt from personal income tax, while those under one month are taxed at 50% of the income [3][4]. - For B share dividends, a 10% corporate income tax will be withheld for non-resident corporate shareholders, resulting in a net dividend of 0.018772 USD per share [6][7].
神奇制药(600613) - 上海神奇制药投资管理股份有限公司2024年年度权益分派实施公告
2025-05-28 09:45
900904 | 神奇B股 证券代码:600613 证券简称:神奇制药 公告编号:2025-019 上海神奇制药投资管理股份有限公司2024年年度权益 分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 1. 发放年度:2024年年度 2. 分派对象: 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任 公司上海分公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 每股分配比例 A 股每股现金红利0.15元,B 股每股现金红利0.020858美元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2025/6/4 | - | 2025/6/5 | 2025/6/5 | | B股 | 2025/6/9 | 2025/6/4 | | 2025/6/23 | 差异化分红送转: 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 ...
神奇制药: 上海神奇制药投资管理股份有限公司关于股东股票质押、解除质押的公告
Zheng Quan Zhi Xing· 2025-05-23 09:16
证券代码:A 股 600613 股票简称:A 股 神奇制药 编号:2025-018 B股 900904 B股 神奇 B 股 上海神奇制药投资管理股份有限公司 关于股东股票质押、解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 一、上市公司股份质押 质 是 是 是 押 否 股 否 否 融 为 本次质押股 质 占其所 占公司 东 为 补 质押起始 质押到期 资 控 数 权 持股份 总股本 名 限 充 日 日 资 股 (万股) 人 比例 比例 称 售 质 金 股 股 押 用 东 途 厦 经 迈 营 门 吉 否 26,670,000 否 否 2025.5.21 2028.5.20 30.31% 4.99% 资 国 金 斯 周 际 转 合 26,670,000 30.31% 4.99% 计 保障用途的情形。 二、解除质押的具体情况 股东名称 迈吉斯 本次解质(解冻)股份 18,259,000 股 占其所持股份比例 20.75% 占公司总股本比例 3.42% | 解质(解冻)时间 | | | | | | ...
神奇制药(600613) - 上海神奇制药投资管理股份有限公司关于股东股票质押、解除质押的公告
2025-05-23 08:45
2025 年 5 月 23 日,公司接到迈吉斯关于股份质押、解除质押的通知:迈吉 斯向厦门国际银行股份有限公司厦门分行(以下简称"厦门国际")办理了股票 质押业务,质押其持有的本公司无限售流通股 26,670,000 股,占公司总股份数 4.99%,占其持有公司股份 30.31%;迈吉斯向山高联储(青岛)产业投资基金合 伙企业(有限合伙)办理了股票解除质押业务,解除质押 18,259,000 股,占公 司总股份数 3.42%,占其持有公司股份 20.75%。具体情况如下: | | | 上海神奇制药投资管理股份有限公司 关于股东股票质押、解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 上海神奇制药投资管理股份有限公司(以下简称"公司"或"本公司") 的股东贵州迈吉斯投资管理有限公司(以下简称"迈吉斯")持有公司 88,001,946 股,占公司总股本 16.48%;本次质押 26,670,000 股,本次解除质 押 18,259,000 股;剩余累计质押股份 63,000,000 股,占公司 ...
神奇制药:迈吉斯质押2667万股并解除1825.9万股
news flash· 2025-05-23 08:18
神奇制药(600613)公告,股东迈吉斯持有公司8800.19万股,占总股本16.48%。本次质押2667万股, 解除质押1825.9万股,剩余质押股份6300万股,占总股本11.80%,占其持有股份71.59%。控股股东神奇 控股及其控股公司迈吉斯合计持有公司1.79亿股,占总股本33.45%,累计质押股份1.23亿股,占总股本 23.11%,占其合计持有股份69.09%。 ...
5月20日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-20 10:19
Group 1 - Hongjing Technology signed a service contract for an intelligent computing project with a total amount of 597 million yuan, valid for 5 years [1] - Weifu High-Tech's subsidiary invested 220 million yuan to establish a joint venture with Shanghai Baolong Automotive Technology [2] - Zhongshan Public received approval for the registration of short-term financing bonds amounting to 2 billion yuan and medium-term notes of 3 billion yuan [3] Group 2 - Lianhua Technology established a venture capital fund with a total commitment of 200 million yuan, contributing 100 million yuan as a limited partner [4] - Changan Technology's shareholder signed an agreement to transfer 6.27% of the company's shares to Hefei State Capital Venture Investment [6] - Hangzhou Garden announced a cash dividend of 0.5 yuan per 10 shares, totaling 6.62 million yuan [8] Group 3 - Huamao Technology plans to acquire 100% equity of Fuchuang Youyue, leading to a temporary suspension of its stock [9] - Zhuojin Co. won a bid for a soil remediation project in Hefei with a contract value of 67.68 million yuan [10] - Shanghai Pharmaceuticals received FDA approval for two drugs, enhancing its product portfolio [10] Group 4 - Fuxing Pharmaceutical's senior vice president resigned for personal reasons [12] - Baolong Technology's subsidiary plans to invest 180 million yuan in a joint venture [13] - ST Zhongdi intends to utilize surplus funds from a project company, with a maximum of 106 million yuan [14] Group 5 - Nanchao Food reported a significant decline in net profit for April, down 82.14% year-on-year [16] - Changshan Pharmaceutical received a drug registration certificate in Belarus for a new product [18] - Nanshan Aluminum established a wholly-owned subsidiary for photovoltaic energy projects with an investment of 5 million yuan [20] Group 6 - Bozhong Precision announced the resignation of a director and deputy general manager [22] - Xinjiang Jiaojian won a bid for a highway construction project valued at 451 million yuan [23] - Guangzhou Restaurant declared a cash dividend of 0.48 yuan per share, totaling 273 million yuan [25] Group 7 - Weili Medical's subsidiary obtained a medical device operating license, allowing it to engage in wholesale activities [27] - New Australia Co. announced a cash dividend of 0.3 yuan per share, totaling 219 million yuan [28] - Lianhua Technology's subsidiary entered the new third board innovation layer [29] Group 8 - Huaxi Energy's chairman resigned due to personal reasons [31] - Yipin Hong plans to use up to 500 million yuan of idle funds for cash management [33] - Shouhua Gas intends to purchase bauxite resources through market means [34] Group 9 - Jincheng signed a service agreement for underground mining operations at the Komakau Copper Mine, valued at approximately 805 million USD [34] - Wanrun New Energy signed a supply contract with CATL for lithium iron phosphate products, with a total supply of about 1.32 million tons [35] - Weili plans to transfer 100% equity of a subsidiary to Chengfa Environment for 100 million yuan [36] Group 10 - Zhenlei Technology's subsidiary received government subsidies of 2.21 million yuan, positively impacting profits [38] - Weir shares plan to change their name to "Haowei Group" to reflect strategic direction [39] - YTO Express reported a revenue increase of 16.32% in April, totaling 5.755 billion yuan [39]
神奇制药(600613) - 上海神奇制药投资管理股份有限公司关于控股股东的一致行动人减持股份计划的公告
2025-05-20 07:32
证券代码:600613 证券简称:神奇制药 公告编号:2025-017 900904 神奇 B 股 上海神奇制药投资管理股份有限公司 关于控股股东的一致行动人减持股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 股东持股的基本情况 截至本公告披露日,上海神奇制药投资管理股份有限公司(以下简称"公 司")股东张娅女士持有公司股份 10,304,700 股,占公司总股本的 1.93%。上 述股份来源于 2023 年 7 月通过大宗交易取得。张娅女士系公司控股股东贵州神 奇控股(集团)公司的一致行动人。 减持计划的主要内容 张娅因个人资金需要,计划通过集中竞价交易和大宗交易方式减持其持有的 公司股份不超过 10,304,700 股。 本次减持计划自本公告披露之日起 15 个交易日后的 3 个月内实施, 且在任意连续 90 日内,通过上海证券交易所集中竞价交易减持股份的总数不超 过公司股份总数的 1%、通过上海证券交易所大宗交易减持股份的总数不超过公 司股份总数的 2%。 上述期间如遇法律法规、 ...
公告精选︱泰禾股份:拟不超1.5亿美元在埃及建设农药及功能化学品项目;百利电气:2024年度相关业务收入占公司整体收入比重不足1%
Ge Long Hui· 2025-05-19 23:50
Key Points - The article highlights various significant announcements from companies, including revenue growth, investment projects, and share buybacks [1][2] Company Announcements - Baili Electric's revenue from related businesses in 2024 will account for less than 1% of the company's total revenue [1] - Taihe Co., Ltd. plans to invest up to $150 million in a pesticide and functional chemicals project in Egypt [1] - Huakang Clean is expected to win a bid for the renovation of the second inpatient building at West China Hospital of Sichuan University [1] - YTO Express reported a revenue of 5.755 billion yuan from express products in April, a year-on-year increase of 16.32% [1] - Shentong Express reported a revenue of 4.118 billion yuan from express services in April, a year-on-year increase of 16.39% [1] - Kangping Technology plans to acquire 100% equity of Souluke Electronics for 198 million yuan [1] - Hexing Packaging intends to repurchase shares worth between 50 million to 100 million yuan [1] - Guangxi Media's controlling shareholder and its concerted parties plan to reduce their holdings by no more than 1% [1] - Huading Co., Ltd. plans to reduce its holdings by no more than 3% [1] - Jingu Co., Ltd. received a notification from a leading global new energy vehicle company [1] - Wanrun New Energy signed a business cooperation agreement with CATL, expecting a total supply volume of approximately 1.3231 million tons [1][2] Investment Projects - Huaheng Biological plans to invest 320 million yuan in an "AI Precision Fermentation and Protein Engineering Shared Demonstration Project" [1] Share Buybacks - Kesi Technology plans to repurchase shares worth between 30 million to 50 million yuan [1] - Zhaoxun Media intends to repurchase 1.66% to 3.33% of its shares [2]